Showing results (21-30 of 215) with videos related to
Sort By:
Pageof 22
The Journal of Antimicrobial Chemotherapy|June 9, 2005
The management of HIV-1 protease inhibitor pharmacokinetic interactionsAlan Winston, Marta BoffitoCurrent HIV/AIDS Reports|June 30, 2016
Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive IndividualsJonathan Underwood, Alan WinstonCurrent Opinion in HIV and AIDS|November 27, 2013
Can antiretroviral therapy prevent HIV-associated cognitive disorders?Alan Winston, Jaime H VeraCurrent Opinion in HIV and AIDS|April 29, 2025
Cognitive impairment in persons with HIV: changing aetiologies and management strategiesAlan Winston, Andrea Calcagno, Paola CinquePharmacogenomics|June 7, 2006
The clinical implications of antiretroviral pharmacogenomicsJulie Fox, Marta Boffito, Alan WinstonCurrent Opinion in Infectious Diseases|November 1, 2005
Host determinants of antiretroviral drug activityMarta Boffito, Alan Winston, Andrew OwenCurrent Opinion in Neurology|June 4, 2025
Brain health in HIV: pathogenesis, classification, and treatmentKathryn B Holroyd, Alan Winston, Sam NightingaleJournal of Neurology, Neurosurgery, and Psychiatry|February 5, 2013
HIV, dementia and antiretroviral drugs: 30 years of an epidemicHadi Manji, H R Jäger, Alan WinstonAIDS Research and Human Retroviruses|August 15, 2009
Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapyLucy J Garvey, Dharani Yerrakalva, Alan WinstonAIDS (London, England)|November 27, 2014
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?Jonathan Underwood, Kevin R Robertson, Alan WinstonPageof 22